Pharmacy Medical News about Gastroenterology

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology
BMC Gastroenterology, 10/12/09

Chavez–Tapia NC et al. – Rimonabant is associated with an increased risk of adverse events. Despite of an increasing interest for its use on fatty liver, the security profile and efficacy it is needs to be carefully assessed before its recommendation. At present the use of rimonabant on fatty liver cannot be recommended.

<< Previous
Extensively drug-resistant tuberculosis treatment outcome in...

Next >>
Effects of raloxifene on the renin–angiotensin–aldosterone system...

Adrenal Cortisol Secretion Capacity in Children and Adolescents with New-Onset, Mild Crohn's Disease
The Journal of Pediatrics, 10/30/09 Relevance Score: 84%

Cross-Sectional Analysis of Health-Related Quality of Life in Pediatric Liver Transplant Recipients
The Journal of Pediatrics, 10/30/09 Relevance Score: 84%

Improved Adherence and Outcomes for Pediatric Liver Transplant Recipients by Using Text Messaging
Pediatrics, 10/28/09 Relevance Score: 84%

Salix Pharmaceuticals Previews American College Of Gastroenterology 2009 Annual Scientific Meeting
Salix Pharmaceuticals, 10/27/09 Relevance Score: 84%

Long-term Clinical Significance of Thyroid Autoimmunity in Children with Celiac Disease
The Journal of Pediatrics, 10/23/09 Relevance Score: 84%